SynerG™ combines advanced PRP, A2M, BMAC, objective outcomes tracking, and physician-led rehabilitation to help appropriate patients stay active longer.
Developed by Harvard-trained orthopedic surgeon Dr. Frank McCormick.
Complete the short form and our team will follow up about next steps.
Most regenerative medicine programs offer a single injection. SynerG™ was designed to offer something more: a comprehensive, physician-led joint preservation system focused on improving joint health, reducing pain, restoring function, and helping patients stay active longer.
Led by Dr. Frank McCormick, a board-certified orthopedic sports medicine surgeon and nationally recognized expert in joint preservation, SynerG™ combines advanced biologic therapies with objective measurement, personalized coaching, and continuous outcome tracking.
Rather than treating a single symptom, SynerG™ evaluates the entire joint ecosystem and creates a personalized roadmap for recovery — helping patients move better, feel better, and potentially delay or avoid more invasive procedures whenever appropriate.
Every treatment begins with understanding where your joint is today — and where it can go tomorrow.
Supports the body's natural healing response, delivered with precision.
A proprietary framework evaluating symptoms, function, imaging, exam findings, biomarkers, and recovery potential to quantify joint health.
Helps protect cartilage and support a healthier joint environment.
A structured recovery program built around nutrition, exercise, mobility, and lifestyle to maximize results.
Objective measurement and continuous process improvement to monitor progress over time.
Designed to help you move better, feel better, and stay active longer.
Through objective data, advanced biologics, and physician-guided optimization — a more comprehensive, measurable approach to joint preservation.
"Excellence Defined by Outcomes. Powered by Precision."
Developed by Dr. Frank McCormick, SynerG™ combines advanced biologic therapies — PRP, A2M, and BMAC — with objective measurement, personalized recovery optimization, and continuous outcome tracking.
Using our proprietary Joint Age™ assessment and 100 Days to Health™ program, we evaluate not only the condition of your joint, but your body's ability to heal, recover, and perform at its highest level.
Download the SynerG™ Joint Preservation Guide and learn how Joint Age™, PRP, A2M, BMAC, and the 100 Days to Health™ framework work together into a personalized strategy.
A complete joint preservation protocol — not just a single injection.
Advanced imaging review and surgeon evaluation to confirm candidacy and map the treatment plan.
Platelet-rich plasma delivered under ultrasound guidance to stimulate the joint's natural repair response.
Alpha-2-macroglobulin neutralizes destructive enzymes that accelerate cartilage breakdown.
Bone marrow aspirate concentrate provides mesenchymal stem cells for deeper tissue repair when indicated.
Designed for patients with mild to moderate arthritis who want to stay active — not those requiring immediate joint replacement.
| Feature | Typical PRP clinic | SynerG™ |
|---|---|---|
| Orthopedic surgeon evaluation | Variable | Yes |
| Advanced imaging review | Variable | Yes |
| Ultrasound-guided treatment | Variable | Yes |
| PRP, BMAC, and A2M options | Limited | Yes |
| Physical therapy integration | Rare | Yes |
| Outcome tracking | Rare | Yes |
| Surgical expertise if needed | Rare | Yes |
| Complete joint preservation plan | Rare | Yes |
Because every patient undergoes a detailed candidacy evaluation and outcome tracking process, availability is intentionally limited.
Hear directly from patients who chose joint preservation with SynerG™.
Many orthobiologic treatments are considered self-pay. Our team will review your options before treatment.
Treatment cost depends on the joint, severity, and biologic treatment plan. Financing options may be available.
SynerG™ may include platelet-rich plasma, bone marrow aspirate concentrate, A2M, and rehabilitation depending on the patient's needs.
For appropriate patients, SynerG™ is designed to help preserve the joint, reduce pain, and delay or potentially avoid joint replacement.
A consultation, exam, and imaging review are required to determine candidacy. We do not accept every patient — every candidate undergoes physician review.